ABAXIS Asset Utilization: 0.84
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ABAX Asset Utilization Rankings
| Overall | 58th percentile | 1753 of 4272 |
| Sector | 66th percentile | 151 of 446 in Healthcare |
| Industry | 82nd percentile | 3 of 17 in Diagnostic Substances |
ABAX Asset Utilization Range, Past 5 Years
| Minimum | 0.04 | Jun 1993 |
| Maximum | 1.80 | Jun 2000 |
| Average |
About Asset Utilization
The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns. This ratio indicates a company's efficiency in using its assets.
For example, with an asset utilization ratio of 52%, a company earned $.52 for each dollar of assets held by the company.
Learn More
You may also be interested in these ABAX related companies
ABAX News
Canaccord Genuity Reiterates a 'Hold' on Abaxis Inc. (ABAX); Misses on Top and Bottom Lines; Lowering Estimates & PT
Jan 27, 10:19AM Street Insider
Jan 27, 10:19AM Street Insider
Listen to $ABAX Q3 2012 earnings call - live at 04:15 PM, ondemand after - http://stks.co/272d
about 17 days ago by earningscast
about 17 days ago by earningscast
Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2012
Jan 26, 4:00PM PR Newswire
Jan 26, 4:00PM PR Newswire
Abaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Jan 26, 7:45AM PR Newswire
Jan 26, 7:45AM PR Newswire
Abaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Jan 17, 7:00AM PR Newswire
Jan 17, 7:00AM PR Newswire
Canaccord Genuity Starts Abaxis Inc. (ABAX) at Hold; Vet and Medical Markets Show Signs of Stabilizing
Jan 06, 8:55AM Street Insider
Jan 06, 8:55AM Street Insider
Abaxis (ABAX) Veterinary Division Announces Development of Quantitative Lyme Test
Dec 27, 8:03AM Street Insider
Dec 27, 8:03AM Street Insider
Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Dec 27, 8:01AM Benzinga
Dec 27, 8:01AM Benzinga
Abaxis, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
Nov 22, 8:00AM PR Newswire
Nov 22, 8:00AM PR Newswire
Here's some stocks ready for a massive squeeze: $ABAX $CBZ $VIVO $ONCY $INWK & $GHDX to name a few http://stk.ly/jLlrtE
about 248 days ago by SharePlanner
about 248 days ago by SharePlanner
$ABAX http://chart.ly/hkccquu Nice move yest. on strong volume closed near HoD. Setting up to challenge recent highs.
about 340 days ago by TheEquitiesRoom
about 340 days ago by TheEquitiesRoom
$ABAX not like $ebix, neg. volume, higher PE with less growth- be careful
about 347 days ago by akminer
about 347 days ago by akminer
5 Set-ups for Thursday. http://bit.ly/hOcej1 $ABAX $CSX $NSC $MTL $VIT
about 347 days ago by PatternProfits
about 347 days ago by PatternProfits
$ABAX http://chart.ly/e97y5fx Stalking this symm. triangle b/o over $27. High short interest also makes it a squeeze candidate.
about 347 days ago by PatternProfits
about 347 days ago by PatternProfits
$ABAX more shares sold by $SEVERSON CLINTON. See holders at http://tinyurl.com/2bs2nva
about 430 days ago by whalewisdom
about 430 days ago by whalewisdom
$ABAX upgraded from Mkt Perform to Mkt Outperform http://bit.ly/bbuT7e #nasdaq
about 572 days ago by NASDAQ
about 572 days ago by NASDAQ
http://chart.ly/6by5dx $ABAX - RT @Briefingcom Avondale ups to Mkt Outperform // Monthly techs look like bottom rail could be tested.
about 572 days ago by Xiphos_Trading
about 572 days ago by Xiphos_Trading
Trade: CALENDAR on $ABAX: -3 JAN10 25 / +3 MAY10 25 CALLS 2.33 http://bit.ly/7XeDS3
about 776 days ago by dbjret
about 776 days ago by dbjret
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABAX | 27.49 | -0.41 | -1.47% | 595.98M |
| LULU | 65.33 | -0.33 | -0.50% | 7.11B |
| MOLX | 27.30 | -0.40 | -1.44% | 4.80B |
| PTEK | 0.62 | -0.01 | -0.90% | 4.30M |
| GRA | 54.83 | -0.27 | -0.49% | 4.05B |
| SCIL | 2.72 | -0.03 | -1.09% | 51.35M |
| CLS | 8.68 | -0.02 | -0.23% | 1.71B |
| BMTI | 2.13 | -0.10 | -4.48% | 59.73M |
| GMCR | 62.85 | -1.40 | -2.18% | 9.72B |
| TM | 78.39 | -2.49 | -3.08% | 122.90B |
